Ankylosing spondylitis: Research Studies
1 Related Result(s)
(ASLeap) Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis
Escalating the dose of Cosentyx is currently one approach for treating certain rheumatologic conditions. The purpose of this study is to discover if it is...
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.